6 Result(s)

Article

Premixed insulin regimens for type 2 diabetes

Apostolos Tsapas, Thomas Karagiannis, Eleni Bekiari in Endocrine (2016)

Article

Management of type 2 diabetes with the dual GIP/GLP-1 receptor agonist tirzepatide: a systematic review and meta-analysis

Tirzepatide is a novel dual glucose-dependent insulinotropic peptide (GIP) and glucagon-like peptide-1 receptor agonist (GLP-1 RA) currently under review for marketing approval. Individual trials have assessed...

Thomas Karagiannis, Ioannis Avgerinos, Aris Liakos, Stefano Del Prato… in Diabetologia (2022)

Article

Socioeconomic aspects of incretin-based therapy

Incretin-based therapies, particularly glucagon-like peptide-1 receptor agonists (GLP-1 RAs), have demonstrated cardiovascular benefits in people with type 2 diabetes. However, socioeconomic disparities in the...

Thomas Karagiannis, Eleni Bekiari, Apostolos Tsapas in Diabetologia (2023)

Article

EZH2 inhibitors promote β-like cell regeneration in young and adult type 1 diabetes donors

β-cells are a type of endocrine cell found in pancreatic islets that synthesize, store and release insulin. In type 1 diabetes (T1D), T-cells of the immune system selectively destroy the insulin-producing β-ce...

Keith Al-Hasani, Safiya Naina Marikar… in Signal Transduction and Targeted Therapy (2024)

Article

Subcutaneously administered tirzepatide vs semaglutide for adults with type 2 diabetes: a systematic review and network meta-analysis of randomised controlled trials

We conducted a systematic review and network meta-analysis to compare the efficacy and safety of s.c. administered tirzepatide vs s.c. administered semaglutide for adults of both sexes with type 2 diabetes mel...

Thomas Karagiannis, Konstantinos Malandris, Ioannis Avgerinos… in Diabetologia (2024)